MONTREAL, QC – May 30, 2024 – MY01, an innovative medical technology company dedicated to revolutionizing the diagnosis of compartment syndrome, is pleased to introduce the appointment of Jason Young as its Director of Sales, United States.
Jason brings with him over two decades of experience in orthopedic sales. He has consistently demonstrated strategic sales leadership and has a proven track record of driving substantial revenue growth and expanding market presence. Jason’s previous roles as a distributor, Director of Sales at Smith & Nephew, and national positions with Anika Therapeutics and Nimble Solutions will significantly enhance our ability to collaborate with key agencies across the United States.
“ We are excited for Jason to join our leadership team ”, said Andrew Morris, Chief Commercial Officer of MY01. “ Jason brings a unique ability to combine clinical expertise with exceptional sales execution, making him the ideal candidate to lead our expansion initiatives. His extensive experience will enable him to effectively communicate the clinical and economic value that MY01 offers to healthcare systems and their patients. ”
“ I’m thrilled to be joining the MY01 team! They are a tremendous group of individuals with a dedicated culture of expertise. The MY01 device stands alone with its ability to harness objective data, providing the clinician with the ability to continuously monitor at-risk patients for compartment syndrome,” shared Jason as he visited the MY01 headquarters in Montreal.
About MY01, Inc
Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, enabling precise, personalized care for all patients. Specializing in managing limb ischemia and compartment syndrome, our tools provide proactive monitoring and actionable insights through a connected care team that benefits patients, providers, and payers. MY01 is commercial in the USA, Europe, and Canada, setting new standards in healthcare.